DOI: 10.1055/s-00000094

Zeitschrift für Gastroenterologie

References

Feagan BG, Rubin DT, Danese S. et al.
Efficacy of Vedolizumab Induction and Maintenance Therapy in Patients With Ulcerative Colitis, Regardless of Prior Exposure to Tumor Necrosis Factor Antagonists.

Clin Gastroenterol Hepatol 2017;
15: 229-239 e5

Feagan BG, Rubin DT, Danese S. et al.
Efficacy of Vedolizumab Induction and Maintenance Therapy in Patients With Ulcerative Colitis, Regardless of Prior Exposure to Tumor Necrosis Factor Antagonists.

Clin Gastroenterol Hepatol 2017;
15: 229-239 e5

Download Bibliographical Data

Search in:
Access: